(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PHARMACOMPLY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PHARMACOMPLY

ST13

US500000078688082

Class

35

Filing

78688082

Registration

3126382

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

08/09/2025

Trademark type

Word

Nice classes

35

Filing date

08/08/2005

Registration date

08/08/2006

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/14/2016

Last transaction

08/09/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

2004-09-00

First use in commerce

2004-09-00

Drawing code

4

Owner type

03

Owner location

LAKEWOOD, NJ

Examiner

AXILBUND, MELVIN

Law office

M40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

J. KNIPPER & COMPANY, INC.
Healthcare Logistics, LLC

Representatives

Susan M. Mulholland Gesmer Updegrove LLP

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

sample accountability servicesmanagement services provided to pharmaceutical manufacturers for controlling drug inventoriessample distribution to pharmaceutical sales representativesrecord-keeping services for use in complying with the Prescription Drug Marketing Actmanagement consultation regarding the foregoing

Publications

History of USPTO decisions and trademark events.

35 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/08/2025

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

06/23/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/04/2022

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/14/2016

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/14/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/14/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/14/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

08/01/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/08/2015

NA15

SEC. 15 ACKNOWLEDGEMENT - E-MAILED

06/12/2014

15AK

REGISTERED - SEC. 15 ACKNOWLEDGED

06/12/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/12/2014

E15R

TEAS SECTION 15 RECEIVED

06/11/2014

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

03/20/2013

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

03/20/2013

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

01/31/2013

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/30/2013

PRA8

POST REGISTRATION ACTION MAILED - SEC. 8

12/03/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/03/2012

8.AF

REGISTERED - SEC. 8 (6-YR) FILED

10/26/2012

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/26/2012

ES8R

TEAS SECTION 8 RECEIVED

10/26/2012

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/22/2010

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/15/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

08/08/2006

PUBO

PUBLISHED FOR OPPOSITION

05/16/2006

NPUB

NOTICE OF PUBLICATION

04/26/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/23/2006

ALIE

ASSIGNED TO LIE

03/21/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/01/2006

XAEC

EXAMINER'S AMENDMENT ENTERED

03/01/2006

GNEA

EXAMINERS AMENDMENT E-MAILED

03/01/2006

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/01/2006

DOCK

ASSIGNED TO EXAMINER

02/27/2006

NWAP

NEW APPLICATION ENTERED

08/15/2005

Continuous trademark protection

Get notified about every new filing that threatens PHARMACOMPLY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.